Chamber for Patent Disputes Takes Decision in Favor of Sojuzpatent’s Client

On August 11, 2010, the Chamber for the Patent Disputes of the Russian Federal Service for Intellectual Property considered opposition against validity in the territory of the Russian Federation of Eurasian patent 00891 “dosing inhaler for propionate of fluticasone” and opposition against validity in the territory of the Russian Federation of Eurasian patent 00892 “dosing inhaler for salmeterol”. The Board Meeting of the Chamber for the Patent Disputes took a decision in favor of Sojuzpatent’s client – LLC Lisentech, satisfying the opposition and recognizing Eurasian patents 00891 and 00892 completely invalid in the territory of the Russian Federation.